急性冠状动脉综合征(ACS)是现有国情下的常见病,其发病率逐年升高,处理急性冠脉综合征经皮冠状动脉介入治疗(PCI)术已经成为主要手段。开展得多,但之后相应的并发症也随之而来,术后再狭窄为其中发生率最高的,虽药物支架解决了一部分但是仍存在。再狭窄是多方因素所至,已经成为困扰心血管内科医师面临的主要问题。再狭窄的机制包括 Acute coronary syndrome (ACS) is a common disease in the current national conditions, the incidence increased year by year, the treatment of acute coronary syndromes percutaneous coronary intervention (PCI) surgery has become the main means. Much has been done, but then the corresponding complications have followed. Restenosis after surgery is the most frequent of these, although the drug scaffolds have been partially resolved but still exist. Restenosis is multifactorial and has become a major problem for the cardiovascular physician. Mechanisms of restenosis include